Keywords vaccines

ACAM2000

FDA

The FDA approved a new indication for ACAM2000, to include the prevention of mpox disease in individuals determined to be at high risk for mpox infection. ACAM2000 has been approved since 2007 for the prevention of smallpox disease in individuals determined to be at high risk for smallpox infection. ACAM2000 is a live replicating vaccinia virus vaccine.

keywords: ACAM2000, Monkeypox, MPOX, poxvirus, vaccines

Half a million children die of malaria every year. Finally we can change that

Nature

11 October 2023

Advisors to the WHO recently recommended a second malaria vaccine.

keywords: malaria, parasites, vaccines

Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023 (Website, Publication)

CDC/MMWR

16 June 2023

Moulia DL, Wallace M, Roper LE, et al.
Updated vaccine recommendations for children > 6 months and adults >65.

keywords: children, covid-19, vaccination, vaccines

Immunization, Vaccines and Biologicals

WHO

WHO Immunization, Vaccines, and Biologicals Department’s list of vaccine-preventable diseases

keywords: vaccines, Waterborne Diseases

Vaccine preventable viral diseases and risks associated with waterborne transmission

Italy / Istituto Superiore di Sanità

Ruggeri FM, Lucia Fiore L

keywords: vaccines, Waterborne Diseases

CDC simplifies COVID-19 vaccine recommendations, allows older adults and immunocompromised adults to get second dose of the updated vaccine

CDC

keywords: ACIP, bivalent, booster, covid-19, Moderna, pfizer, vaccines

Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months–5 Years — United States, June 17, 2022–May 7, 2023 (Website, Publication)

CDC/MMWR

9 June 2023

Hause AM, Marquez P, Zhang B, et al.

keywords: children, covid-19, mRNA, vaccination, vaccines

USDA starts highly pathogenic avian influenza vaccine trials

American Veterinary Medical Association (AVMA)

1 May 2023

keywords: HPAI, Influenza Virus, vaccines

Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period — IVY Network, 19 U.S. States, February 1, 2022–January 31, 2023

CDC/MMWR

28 April 2023

DeCuir J, Surie D, Zhu Y, et al.

keywords: covid-19, monovalent vaccine, omicron, vaccines

Interim Estimates of 2022–23 Seasonal Influenza Vaccine Effectiveness — Wisconsin, October 2022–February 2023

CDC/MMWR

24 February 2023

McLean HQ, Petrie JG, Hanson KE, et al.
The 2022–23 influenza vaccine provides substantial protection against circulating influenza A viruses and remains the best way to protect against influenza. Influenza vaccination is recommended as long as influenza viruses are circulating.

keywords: Influenza Virus, vaccines

Resources with keywords: vaccines